Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 10/20 | 0.84 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.84 |
| ▸ | MAPT | P10636 | 8/20 | 0.84 |
| ▸ | FAAH | O00519 | 1/20 | 0.76 |
| ▸ | IDE | P14735 | 2/20 | 0.73 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.73 |
| ▸ | POLB | P06746 | 3/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | HTT | P42858 | 1/20 | 0.67 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.57 |
| ▸ | BLM | P54132 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | PIM1 | P11309 | 2/20 | 0.55 |
| ▸ | PIM3 | Q86V86 | 2/20 | 0.55 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.55 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 3/20 | 0.53 |
| ▸ | FABP4 | P15090 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1641528 | 1.00 | MEN1 (0.84) | MEN1KMT2AMAPTFAAHIDE | |
| SCHEMBL1421695 | 0.92 | MEN1 (0.71) | MEN1KMT2AMAPTFAAHIDE | |
| SCHEMBL1421699 | 0.92 | MEN1 (0.71) | MEN1KMT2AMAPTFAAHIDE | |
| SCHEMBL1421701 | 0.92 | MEN1 (0.71) | MEN1KMT2AMAPTFAAHIDE | |
| SCHEMBL1421482 | 0.90 | FAAH (0.73) | MEN1KMT2AMAPTFAAHIDE | |
| SCHEMBL1421478 | 0.90 | FAAH (0.73) | MEN1KMT2AMAPTFAAHIDE | |
| SCHEMBL17309377 | 0.86 | FAAH (1.00) | MEN1KMT2AMAPTFAAHIDE | |
| SCHEMBL17309315 | 0.86 | FAAH (1.00) | MEN1KMT2AMAPTFAAHIDE | |
| SCHEMBL1421308 | 0.82 | FAAH (0.62) | MEN1KMT2AMAPTFAAHIDE | |
| SCHEMBL1421306 | 0.82 | FAAH (0.62) | MEN1KMT2AMAPTFAAHIDE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110098323-A1 | INHIBITORS OF BACTERIAL BIOFILM FORMATION | MICROBIOTIX, INC. (US) | 2011-04-28 | — | — | US | disclosed |
| EP-2296476-A1 | INHIBITORS OF BACTERIAL BIOFILM FORMATION | Microbiotix, Inc. (US) | 2011-03-23 | — | — | EP | disclosed |
| WO-2009142720-A1 | INHIBITORS OF BACTERIAL BIOFILM FORMATION | MICROBIOTIX, INC. (US) | 2009-11-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110098323-A1 | INHIBITORS OF BACTERIAL BIOFILM FORMATION | BLVRB, TFPI, FOSB | MEN1 4836/4885KMT2A 3896/4885MAPT 4065/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.